Hussam Albassam

Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers

Mohammed M. Alanazi, Ibrahim H. Eissa, Nawaf A. Alsaif et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2021 · 91 citations · Full text

Urolithin A induces prostate cancer cell death in p53-dependent and in p53-independent manner

Yasir I. Mohammed Saleem, Hussam Albassam, Mustafa I. Selim · European Journal of Nutrition · 2019 · 55 citations

Urology, Genitourinary Cancer, P53-independent Manner +3

Blockade of interleukin-2-inducible T-cell kinase signaling attenuates acute lung injury in mice through adjustment of pulmonary Th17/Treg immune responses and reduction of oxidative stress

Ahmed Nadeem, Naif O. Al‐Harbi, Sheikh F. Ahmad et al. · International Immunopharmacology · 2020 · 55 citations

Inflammation, Acute Lung Injury, Cytokine +12

Immunoinformatics-guided design of a multi-epitope vaccine based on the structural proteins of severe acute respiratory syndrome coronavirus 2

Ahmad J. Obaidullah, Mohammed M. Alanazi, Nawaf A. Alsaif et al. · RSC Advances · 2021 · 48 citations · Full text

Identification of new [1,2,4]triazolo[4,3-a]quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, anticancer evaluation, and in silico studies

Nawaf A. Alsaif, Mohammed S. Taghour, Mohammed M. Alanazi et al. · Bioorganic & Medicinal Chemistry · 2021 · 33 citations · Full text

Medicinal Chemistry, Medicine, Rational Drug Design +9